Location: Home
  • search
  • go
  • Relate News
  • 11/5/2025Merck Secures $700M Funding from Blackstone for TROP2-Targeting ADC C...
  • 11/5/2025US Dollar Funds Make a Comeback in China's Innovative Drug Market: VBD...
  • 11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...
  • 11/5/2025China to Expand Use of Artificial Intelligence Across Health Sector by...
  • 11/5/2025Bayer Deepens Investment in China's Booming Biopharma Sector
  • 11/5/2025Senior CSPC Executive Fined CNY 5M for Insider Trading
  • 11/5/2025China Expands Drug Access Through 11th National Bulk-Buy and New 2025 ...
  • 11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval
  • 11/5/2025MNCs Retreat as China Cancels Dozens of Branded Medicines Amid Price C...
  • 11/5/2025China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative ...
  • 11/4/2025Everest Acquires Exclusive Greater China and Other Asian Country Right...
  • 11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
  • 11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
  • 11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...
  • 11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...
  • 11/4/2025China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...
  • 10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
  • 10/31/2025Asia Regenerative Medicine Completes Series A Funding
  • 10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...
  • 10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...
  • 10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
  • 10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 10/31/2025China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...
  • 10/31/2025China Overhauls Drug Procurement and Reimbursement Framework to Balanc...
  • 10/29/2025Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...
  • 10/29/2025NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...
  • 10/29/2025Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...
  • 10/29/2025Pharmaron to Acquire Biortus in China
  • 10/29/2025NHSA Launches Public Consultation Module for DRG Payment Grouping Plan...
  • Page:3/373 Total number of articles:11164: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group